Skip to content

Clinical trials

Phase 2 Hyperlipoproteinemia Type II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipoproteinemia Type II Phase: Phase 2 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20063
20071
20092
20101
20114
20121
20131
20161
20171
20201
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Recruiting2
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kastle Therapeutics, LLC3
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.2
Cerenis Therapeutics, SA2
Ferrer Internacional S.A.2
Medical Research Laboratories International2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Akros Pharma Inc.1
Amgen1
Cortria Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipoproteinemia Type II25
Homozygous Familial Hypercholesterolemia4
Hypercholesterolemia4
Atherosclerosis2
Dyslipidemias2
Hyperlipidemias2
Lipid Metabolism Disorders2
Metabolic Diseases2
Congenital Abnormalities1
Diabetes Mellitus1

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.